BRIEF published on 05/05/2026 at 17:05, 18 days 2 hours ago Medacta Group SA clôture une assemblée générale annuelle réussie Réélection Du Conseil D'administration Rapports Financiers Participation Des Actionnaires Approbation Des Dividendes Assemblée Générale Annuelle De Medacta
BRIEF published on 05/05/2026 at 17:05, 18 days 2 hours ago Medacta Group SA Concludes Successful Annual General Meeting Financial Reports Shareholder Participation Board Re-election Dividend Approval Medacta AGM
PRESS RELEASE published on 05/05/2026 at 17:00, 18 days 2 hours ago Medacta announces the results of today's Annual General Meeting Medacta Group SA announced the results of the Annual General Meeting, with approval of all proposals, CHF 21.9 million distribution, and re-election of Board members Board Of Directors Annual General Meeting Dividend Distribution Medacta Group SA AGM Results
BRIEF published on 04/01/2026 at 06:05, 1 month 22 days ago Medacta rejoint le projet international de renaissance des dinosaures Biotechnologie Medacta Projet De Recherche Dinosaures Tyrannosaure Rex
BRIEF published on 04/01/2026 at 06:05, 1 month 22 days ago Medacta Joins International Dino-Revival Project Biotechnology Medacta Research Project Dinosaurs Tyrannosaurus Rex
PRESS RELEASE published on 04/01/2026 at 06:00, 1 month 22 days ago Medacta selected as partner for groundbreaking international research project Medacta selected to join international research project aiming to recreate dinosaurs from DNA samples, collaborating with leading scientists for specialized orthopaedic hip prosthesis development Scientific Collaboration Medacta Dinosaur Research DNA Samples Orthopaedic Hip Prosthesis
BRIEF published on 03/13/2026 at 07:05, 2 months 10 days ago Medacta Group annonce des résultats records pour 2025 et des perspectives positives. Croissance Des Revenus Stratégie D'innovation Groupe Medacta Expansion Du Marché Résultats Financiers 2025
BRIEF published on 03/13/2026 at 07:05, 2 months 10 days ago Medacta Group Announces Record 2025 Results and Positive Outlook Revenue Growth Market Expansion Innovation Strategy Medacta Group 2025 Financial Results
PRESS RELEASE published on 03/13/2026 at 07:00, 2 months 10 days ago Medacta Group SA: Medacta Group reports record results in Full Year 2025 and upgrades mid-term guidance Medacta Group reports record results for FY 2025 with revenue of Euro 683.8 million and upgrades mid-term guidance, focusing on sustainable innovation and global growth Innovation Revenue Growth Record Results Mid-term Guidance Medacta Group
BRIEF published on 02/03/2026 at 07:05, 3 months 20 days ago Medacta Group Reports Remarkable 18.5% Revenue Growth in 2025 Revenue Growth Regional Performance Medacta Group Medical Innovations 2025 Financials
Published on 05/23/2026 at 03:15, 15 hours 58 minutes ago UraniumX Approved for Trading on the OTCQB Venture Market and Announces Board Change
Published on 05/23/2026 at 03:00, 16 hours 13 minutes ago Battery X Metals Reports Up to ~84 km Estimated Driving Range Increase Across Multiple BYD Electric Vehicles Following Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Trials, Demonstrating Performance Improvement Across the World’s Larges
Published on 05/23/2026 at 02:25, 16 hours 48 minutes ago Battery X Metals Announces up to $2 Million Private Placement Financing and Initiative to Strengthen Balance Sheet
Published on 05/23/2026 at 02:25, 16 hours 48 minutes ago Bolt Metals Completes 402 line-km MobileMT Survey at Northwind Property, Quebec
Published on 05/23/2026 at 01:00, 18 hours 13 minutes ago LIR Life Sciences Announces Initiation of Phase 1 Macromolecule-Enabled Transdermal Delivery Development with Neuland Laboratories
Published on 05/23/2026 at 16:30, 2 hours 42 minutes ago HiFS 2026: Upgrading Four Major Digital Finance Solutions to Accelerate Financial Institutions Toward Agentic Banking
Published on 05/23/2026 at 15:57, 3 hours 16 minutes ago EQS-Adhoc: Delivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
Published on 05/22/2026 at 22:05, 21 hours 8 minutes ago Abivax présente ses résultats financiers du T1 2026 et les données à trois ans de l’étude 108, un essai d’extension ouvert de phase 2a/2b évaluant l’obéfazimod après réduction de dose dans la RCH
Published on 05/22/2026 at 22:05, 21 hours 8 minutes ago Abivax Presents Q1 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with UC
Published on 05/22/2026 at 19:51, 23 hours 21 minutes ago Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Redemption Prices
Published on 05/22/2026 at 19:35, 23 hours 38 minutes ago PROJET D'EVOLUTION DE SA GOUVERNANCE ET LA NOMINATION D'UN PRESIDENT DU DIRECTOIRE PAR INTERIM
Published on 05/22/2026 at 18:05, 1 day 1 hour ago Déclaration hebdomadaire d'opérations effectuées du 18 au 22 mai 2026
Published on 05/22/2026 at 18:05, 1 day 1 hour ago Disclosure of transactions in own shares from May 18 to May 22, 2026
Published on 05/22/2026 at 12:52, 1 day 6 hours ago Communiqué du Conseil d’administration – Assemblée Générale du 22 mai 2026
Published on 05/22/2026 at 12:52, 1 day 6 hours ago Release from the Board of Directors - Shareholders’ Meeting of May 22, 2026
